| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 214,216 | 246,146 | 292,852 | | Cost of Revenue | 101,070 | 126,668 | 140,714 | | | Gross Profit | 113,146 | 119,478 | 152,138 | | | Operating Expenses | | Research Development | 84,687 | 97,550 | 96,418 | | Selling General and Administrative | 50,097 | 61,907 | 67,971 | | Non Recurring | 231,805 | 76,676 | 19,935 | | Others | 4,020 | 5,321 | 4,995 | | | | Total Operating Expenses | 370,609 | 241,454 | 189,319 | | | | Operating Income or Loss | (257,463) | (121,976) | (37,181) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,577) | 10,596 | 13,379 | | Earnings Before Interest And Taxes | (265,040) | (111,380) | (23,802) | | Interest Expense | 4 | 17 | 4 | | Income Before Tax | (265,044) | (111,397) | (23,806) | | Income Tax Expense | (3,946) | 3,724 | 402 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (261,098) | (115,121) | (24,208) | | | Non-recurring Events | | Discontinued Operations | (48,235) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (309,333) | (115,121) | (24,208) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($309,333) | ($115,121) | ($24,208) |
|
1.52% Nasdaq 
Income Statement
